The need to first zero in on a blood group can delay blood transfusions in emergency situations, and this in turn can prove fatal. Thus, to speed up the process, a team of scientists from Tokyo University of Science, Japan, has developed a lab-on-a-chip device that can not only tell the blood type within five minutes but allows medical staff to read the results through simple visual inspections.
Blood transfusion, if performed promptly, is a potentially life-saving intervention for someone losing a lot of blood. However, blood comes in several types, some of which are incompatible with others. Transfusing an incompatible blood type can severely harm a patient. It is, therefore, critical for medical staff to know a patient’s blood type before they perform a transfusion.
There are four major blood types?O, A, B, and AB. These types differ based on the presence or absence of structures called A antigens and B antigens on the surfaces of red blood cells. Blood can be further divided into positive and negative types based on the presence or absence of D antigens on red blood cells. Medical professionals usually tell a patient’s blood type with tests involving antibodies against the A and B antigens. When antibodies recognize the corresponding antigens, they bind to them, causing the blood cells to clump together and the blood to coagulate. Thus, specific antigen-antibody combinations tell us what the blood type of a blood sample is.
Yet, while the concept sounds straightforward, the equipment and techniques required are often very specialized. Tests, therefore, are non-portable, have high personnel cost, and can take over half an hour to yield results. This can prove problematic in several types of emergency situations.
Aiming to solve these problems, a team of scientists at Japan’s Tokyo University of Science, led by Dr Ken Yamamoto and Dr Masahiro Motosuke, has developed a fully automated chip that can quickly and reliably determine a patient’s blood type. In the words of Dr Motosuke, he and his colleagues “have developed a compact and rapid blood-typing chip which also dilutes whole blood automatically.”
The chip contains a micro-sized “laboratory” with various compartments through which the blood sample travels in sequence and is processed until results are obtained. To start the process, a user simply inserts a small amount of blood, presses a button, and waits for the result. Inside the chip, the blood is first diluted with a saline solution and air bubbles are introduced to promote mixing. The diluted blood is transported to a homogenizer where further mixing, driven by more intensely moving bubbles, yields a uniform solution. Portions of the homogenized blood solution are introduced into four different detector chambers. Two chambers each contain reagents that can detect either A antigens or B antigens. A third chamber contains reagents that detect D antigens and a fourth chamber contains only saline solution, with no reagent, and serves as a negative control chamber in which the user should not observe any results. Antigen-antibody reaction will cause blood to coagulate, and by looking at which chambers have coagulated blood, the user can tell the blood type and whether the blood is positive or negative.
Further, the user does not require specialized optical equipment to read the results. The design of the detector chambers allows the easy identification of coagulated blood with the naked eye. The device is also highly sensitive and can even detect weak coagulation.
During testing, the research team screened blood samples from 10 donors and obtained accurate results for all 10 samples. The time needed to determine a single sample’s blood type was only five minutes.
Reflecting on the potential benefits of his team’s invention, Dr Motosuke remarks, “The advancement of simple and quick blood test chip technologies will lead to the simplification of medical care in emergency situations and will greatly reduce costs and the necessary labor on parts of medical staff.” Given the highly portable nature of the chip, Professor Motosuke also speculates that it could be used during aerial medical transport and in disaster response settings. This is a chip that has the potential to change the way emergency medical support is given.
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Identifying blood type
- Protein marker unveiled for identifying blood vessel repair cells
Researchers have discovered a protein marker to help identify cells able to repopulate in patients with damaged blood vessels.
- Can our genes predict our high blood pressure risk?
One in every three adults globally has high blood pressure ... commented that in the past few years, these types of genome-wide association studies have proven to be powerful in identifying genetic ...
- Novel vaccine approach targets AML and other blood cancers
Acute myeloid leukemia (AML) is a type of blood cancer that forms in the soft marrow of the bones, typically attacking cells that would otherwise form the key component of the body's immunodefense ...
- Universal donor blood is 'close' to reality
Around 50% of people naturally have type O or "universal" blood, but those with type A, type B and the rarer type AB blood can currently only give and receive blood from their own group. This is ...
- Novel Blood Biomarkers Show Potential for Early Liver Cancer Diagnosis
While the number of cases in the study was small because the natural incidence of HCC is low, the results were consistent across data sets, populations, and assay types ... Researchers identify ...
Go deeper with Google Headlines on:
Identifying blood type
[google_news title=”” keyword=”identifying blood type” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
Lab-on-a-chip device
- First implant of Elon Musk’s brain chip company malfunctions
The first ever chip implanted into a human brain by Elon Musk’s Neuralink company has malfunctioned, it has announced.
- Korean AI Chip Startup Raises $80 Million Round Led By Ex-Samsung Executive’s Private Equity Firm
D eepX, a South Korean AI chip startup, has raised a $80 million Series C round at a $530 million valuation. The Series C was led by Skylake Equity Partners. The rest came from South Korean private ...
- AI chip startup DEEPX secures $80M Series C at a $529M valuation
DEEPX is a South Korean on-device AI chip (NPU, or neural processing unit) startup that makes hardware and software for various AI applications in electronic devices. The company announced this week ...
- New phononics materials may lead to smaller, more powerful wireless devices
What if your earbuds could do everything your smartphone can do already, except better? What sounds a bit like science fiction may actually not be so far off. A new class of synthetic materials could ...
- Neuralink brain-chip implant encounters issues in first human patient
Elon Musk's Neuralink finds a brain-computer interface device captured less data a month after implant surgery.
Go deeper with Google Headlines on:
Lab-on-a-chip device
[google_news title=”” keyword=”lab-on-a-chip device” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]